1. Introduction
The identification of a ventricular arrhythmia’s origin may be difficult using a standard 12-lead electrocardiogram (ECG), especially if it arises in complex anatomic sites [1,2,3]. However, its accurate localization is relevant not only for the ablation therapy outcome, but also because it can influence the procedural time and the radiation exposure.
Non-invasive electrocardiographic imaging (ECGI, Brussels, Belgium) is a modern technology whose first application in humans was demonstrated in the seminal articles of Rudy Y et al. [4]. Since then, there has been rapid growth in interest and, as a consequence, emergence of different commercial systems [5,6,7,8,9,10,11]. Despite a number of differences (total number of electrodes used, compatibility with different types of imaging methodologies) most known systems have a similar operating principle. It implies the combined integration of non-invasive electrocardiographic recordings and cardiac computer tomographic (cCT) or magnetic resonance imaging (cMRI) data. One of the systems registered on the market and installed in our clinic is the Amycard 01C (EP Solutions SA, Yverdon-les-Bains, Switzerland). The accuracy of the Amycard 01C technology has been described in patients with implanted pacemakers [7,12,13] via invasive stimulation using an invasive 3-dimensional (3D) CARTO mapping system [7] and with ventricular arrhythmias [14,15,16,17,18].
In the present three-case series, we compare the non-invasive and invasive 3D models to qualitatively and quantitatively evaluate the concordance between the two technologies (Amycard 01C and EnSite NavX Precision, Abbott, Chicago, IL, USA) in identifying the early activation zone (EAZ) in patients with premature ventricular contractions (PVCs).
2. Case Presentation
2.1. Case N1
A patient with ischemic cardiomyopathy and previous multiple coronary angioplasties was referred for the treatment of symptomatic monomorphic PVCs (burden 20–50%). A transthoracic echocardiography showed reduced systolic function of the left ventricle (LV). The 12-lead ECG demonstrated sinus rhythm and frequent monomorphic PVCs with a superior axis and a right bundle branch block pattern, with R/S transition in the V4-V5 on the precordial leads (Figure 1).
Other characteristics of the arrhythmia are presented in Table 1.
The workflow of the current study included several steps (Figure 2).
In the first step, multichannel ECG registration during sinus rhythm on the Amycard 01C system (EP Solutions SA, Yverdon-les-Bains, Switzerland) was performed. Dedicated 8-electrode strips compatible with cCT were placed on the patient’s torso. In total, 26 strips corresponding to 208 unipolar body surface metal ECG electrodes were used. The number of strips and unipolar body-surface electrodes implemented for each patient is shown in Table 2.
Typical clinical PVCs were registered and captured. The anonymized ECG tracings with PVCs were saved in ‘ecg.240’ format for further analysis.
In the second step, the patient underwent cCT (Somatom Definition Edge 126, Siemens AG, Munich, Germany). A low-dose thorax scan (‘LungLowDose’ without contrast and a thickness equal to 2 mm), as a first series, helped to identify the anatomical localization of the metal body-surface electrodes and the individual torso anatomy (Figure 3A,B). An ECG-gated contrast scan of the heart with a thickness equal to 0.75 mm (Figure 3C), as a second series, was achieved using automated intravenous injection of a non-ionic contrast (Solutrast 370—100 mL) during a breath hold. A retrospective acquisition protocol was used. The tomography data were exported in Dicom format.
In the third step, an electroanatomic mesh was reconstructed, and non-invasive isochronal maps of the ventricles were generated using the multichannel ECG and the cCT data. Model reconstruction (with 597 LV mesh nodes) and the creation of isochronal maps were carried out by dedicated software version 2.3.0 (Amycard 01C, EP Solutions SA, Yverdon-les-Bains, Switzerland). Subsequently, the EAZ was evaluated. This zone corresponded to the red-colored area on the automatically generated endocardial non-invasive isochronal map, and a white marker was added to point out the earliest activation site inside the EAZ. Afterwards, a qualitative assessment of the location of the EAZ during a typical PVC was performed. The quantitative analysis included two types of measurements. Calculation of the distance from the border of the EAZ (red color) to the atrioventricular annulus, as demonstrated in Figure 4, was the first measure. A measurement of the EAZ area (red color) was the second one.
In the fourth step, the invasive analysis was obtained by a point-by-point endocardial activation mapping of the LV, with a total of 256 points, using the EnSite NavX Precision system (Abbott) with an irrigated deflectable contact-force ablation catheter (TactiCath SE, Abbott) and with a high-density multipolar mapping catheter (AdvisorTM HD-Grid, Abbott). Mapping of LV was performed after transseptal puncture. Invasively, the EAZ position was identified qualitatively and quantitatively as the earliest endocardial activation during the PVCs (i.e., local bipolar ventricular electrograms before the onset of the surface QRS complex and a QS complex on unipolar recordings). In addition, a quantitative analysis using the same metrics as the non-invasive mapping was performed.
The non-invasive and invasive isochronal maps revealed the earliest activation of the dominant PVC on the endocardial surface of the inferior wall of the LV. This area extended to the midventricular inferior wall, near the base of the posteromedial papillary muscle. After identifying the PVCs’ origin point, radiofrequency energy was delivered using a power of 30 to 40 W with a temperature not exceeding 42 °C degrees. Radiofrequency ablation was performed in the early activation area, abolishing the clinical PVCs. A recorded invasive endocardial model with an isochronal map was extracted in text format from the EnSite NavX Precision system.
In the fifth step, extraction and further import of the non-invasive and invasive models in text format into a custom written software in Python version 3.9 was performed in the same manner as in the previous study of Zubarev et al. [19]. In this step, 3D fusion was created based on combining the non-invasive and invasive models with isochronal maps using an iterative nearest point algorithm. Finally, in the merged model, the distance between the earliest activation site labeled with the white marker on both the non-invasive and invasive map, respectively, was measured, as in Figure 5.
The distance from the EAZ to the annulus was 36 millimeters (mm) versus 41 mm on the invasive and non-invasive mapping, respectively (Figure 4). The area of the EAZ was also similar between the invasive/non-invasive maps (4.3 versus 4.5 cm2) (Table 3).
The distance between the earliest activation site on the invasive and non-invasive isochronal maps equaled 4 mm (Figure 5).
The qualitative and quantitative analysis results are summarized in Table 3.
2.2. Case N2
A patient without known structural cardiomyopathy was referred to our center, presenting a long history of highly symptomatic PVCs with a burden up to 30% during Holter monitoring. A transthoracic echocardiography showed preserved systolic function of the LV. Antiarrhythmic therapy with a beta-blocker and additional flecainide and subsequent administration of propafenone were able to reduce but not able to suppress the PVCs (burden after therapy 15–20%).
The 12-lead ECG demonstrated sinus rhythm and frequent monomorphic PVCs with a superior axis, right bundle branch type of morphology, with R/S transition in the V2-V3 precordial leads (Figure 6).
The characteristics of the arrhythmia are presented in Table 1.
In case N2, 28 strips corresponding to 224 unipolar body surface MRI-compatible carbon electrodes were placed onto the patient’s torso and used for ECG recording during sinus rhythm (Table 2). Typical clinical PVCs were registered and captured.
The patient underwent cMRI (Magnetom Skyra 3 T, Siemens AG, Munich, Germany). A coronal T1_vibe_fat-sat sequence with a thickness of 2 mm, field of view (FOV) of 500 × 500 mm, and 160 images in the coronal plane before contrast medium administration allowed detection of the full anatomical torso with the applied carbon ECG strips (Figure 3D,E). The transversal T1_vibe_fat-sat sequence with a thickness of 1.2 mm, an FOV of 380 × 380 mm, and 144 images after intravenous administration of contrast medium (Gadovist 0.1 mmol/mL—6 mL) during a breath hold helped to acquire the full heart (Figure 3F).
Non-invasive, invasive, and fusion data analyses using the MRI data were performed in the same manner as in case N1. Invasive mapping of the LV was performed through foramen ovalis. The numbers of LV points used in the non-invasive and invasive mapping were 825 and 150, respectively.
The EAZ of a typical PVC was located on the inferoseptal apical part of the LV. Our invasive mapping demonstrated that the measured distance from the EAZ to the mitral annulus amounted to 73 mm. Similarly, the distance on the non-invasive map was 75 mm (Table 3).
The area of the EAZ was concordant between the invasive/non-invasive mapping (7.1 versus 7 cm2) (Table 3).
The correspondence between these two methods was represented on a merged image with a difference of 7 mm (Figure 7). Successful endocardial ablation with no PVC recurrence at a six-month follow-up was achieved.
2.3. Case N3
A patient symptomatic for dyspnea on exertion during bigeminy and frequent PVCs without any known structural cardiomyopathy was referred to our cardiology department. Therapy with a beta-blocker and propafenone was not effective. The PVCs’ burden varied between 3 and 5%. A transthoracic echocardiography demonstrated preserved systolic function of the LV.
The 12-lead ECG demonstrated sinus rhythm and frequent monomorphic PVCs with a narrow QRS (120 ms), discordance in the QRS complex (positive in II and negative in III lead), Qr morphology in the V1 precordial lead, and right bundle branch block morphology in V2 (Figure 8).
The characteristics of the arrhythmia are presented in Table 1.
In case N3, 21 strips corresponding to 168 unipolar body surface CT-compatible electrodes were used for ECG recording during sinus rhythm (Table 2). Typical clinical PVCs were registered and captured.
The patient underwent cCT in the same manner as in case N1. A retrospective ECG-gated scan of the heart was performed with contrast medium administration (Ultravist 370—70 mL).
The non-invasive, invasive, and fusion data analyses were conducted in the same manner as in case N1. Both ventricular chambers were mapped during the invasive procedure. Invasive mapping of the LV was performed after transseptal puncture. The number of RV points used in the non-invasive and invasive mapping was 623 and 250, respectively.
On the non-invasive and invasive isochronal maps, the EAZ was located in the basal part of the right ventricle (inferoseptal, near the tricuspid annulus). The distance from the EAZ to the tricuspid annulus was 9 mm versus 12 mm on the invasive and non-invasive mapping, respectively. The area of the EAZ was 0.4 cm2 on the invasive and 0.6 cm2 on the non-invasive isochronal map, respectively (Table 3).
The distance between the earliest activation site on the fusion model was 4 mm (Figure 9).
3. Discussion
A search of the literature exhibits a large number of works devoted to ECGI and invasive mapping, mainly of the endocardium and, to a lesser extent, of the epicardium in ventricular arrhythmias [7,9,10,14,15,16,17,18,20,21,22,23,24,25,26,27,28]. The majority of such works used the invasive 3D mapping CARTO system (Biosense Webster, Irvine, CA, USA) [7,8,9,10,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31], which could be easily explained by its overwhelming market presence. However, there are also some other systems, such as EnSite NavX Precision (Abbott, Chicago, IL, USA), which we use daily in our work. To our best knowledge, this is the first time a series of cases has highlighted a qualitative and quantitative comparison of non-invasive ECGI (Amycard 01C, EP Solutions SA) with invasive mapping from EnSite NavX Precision, Abbott.
The used non-invasive mapping system is able to work with both contrast cCT and cMRI, so we could include both patients’ categories in the current analysis. Furthermore, our system’s choice was based on the fact that the system provides information not only about the epicardium, but also about the ventricular endocardium. This might be an important clinical component, since most ectopic beats have an endocardial origin.
While conducting the current investigation, we realized that it is a team effort that requires certain skills. A full-fledged clinical study requires the participation of at least one electrophysiologist and one radiologist involved in cardiac imaging.
The qualitative analyses in each of the three cases showed the same early localization of the dominant PVC on the endocardial surface when comparing the non-invasive and invasive isochronal maps. Our results are in line with earlier publications demonstrating the feasibility of the ECGI provided by the Amycard 01C system [14,15,16,17,18,25].
Novel in the current work is also the comparative quantitative analysis between technologies (invasive versus non-invasive). First, a similar measurement of the distance between the EAZ and atrioventricular annulus was obtained. In all three cases, the results were comparable between the invasive and non-invasive data (36/41 mm in case N1, 73/75 mm in case N2, 9/12 mm in case N3). Invasively, the location of the annulus was established based on the electrical signals typical for the annular zone and not anatomically, as during the ECGI. This may be the cause of the small differences observed between the two technologies. Second, the area of EAZ was also similar between the invasive/non-invasive maps (4.3/4.5 cm2 in case N1, 7.1/7.0 cm2 in case N2, 0.4/0.6 cm2 in case N3). To our knowledge, this is the first study showing such quantitative comparison.
Furthermore, a fusion of both the non-invasive and invasive isochronal maps was performed in order to evaluate the concordance between the two technologies in localizing the EAZ in patients with PVCs. Similarity between the earliest activation site on the non-invasive and invasive isochronal maps was quite high (4 mm in case N1, 7 mm in case N2, 4 mm in case N3). It should be taken into account that the tip of an invasive catheter is 4 mm long with a diameter of 7 French, which is why the aforementioned accuracy between the maps can be considered high. It is also worth noting that the reported errors already include a potential mismatch between the cardiac positions in sinus rhythm (the source for cCT anatomical reconstructions) and PVC beats (the source for invasive mapping and electrocardiographic reconstructions).
All the presented quantitative measurements demonstrate the reliability of a non-invasive approach in order to plan and guide invasive treatment in the clinical practice. Particularly, a non-invasive assessment can be useful in cases of intermittent ventricular ectopias, as it seems to be sufficient to register a single beat for analysis and, therefore, to overcome difficulties during invasive ablation procedures in which the PVCs are neither present nor inducible. Furthermore, this technology could be useful in complex PVC cases originating from the LVOT/RVOT areas, where ECG interpretation might be ambiguous.
4. Conclusions
This is the first case series with PVCs to demonstrate a qualitative and quantitative comparison of non-invasive ECGI (Amycard 01C, EP Solutions SA) with invasive mapping (EnSite NavX Precision, Abbott).
The distance from the EAZ to the annulus and the EAZ area as parameters for matching isochronal maps were similar when comparing the non-invasive and invasive models.
The similarity between the earliest activation site on the non-invasive and invasive isochronal maps was sufficient and appropriate to trust the preoperative analysis in these cases. Although these findings lack statistical power, the presented case results encourage further investigations.
Conceptualization, D.B. and L.V.-S.; Methodology, D.B. and L.V.-S.; Software, S.Z. and A.D.; Validation, D.B. and A.D.; Formal analysis, M.M., S.Z., D.B., V.B. and L.V.-S.; Investigation, D.B., J.W., V.B., H.R. and L.V.-S.; Data curation, M.M., J.W. and A.D.; Writing—original draft, M.M., S.Z., D.B. and L.V.-S.; Writing–review & editing, D.B., J.W., V.B., H.R. and T.B.; Visualization, S.Z.; Supervision, L.V.-S. All authors have read and agreed to the published version of the manuscript.
Being the topic of a feasibility pilot study, the postprocessing analysis using anonymized data from the clinical routine without any influence on the clinical decisions regarding patient management did not require approval from an ethics committee.
Written informed consent for diagnostic and invasive procedures was obtained from all the subjects involved in the study. Written informed consent to use anonymized data according to privacy regulation has been obtained from the patients.
This data can be found here: [
We greatly appreciate the help of Danila Potyagaylo (EPIQure GmbH, Nuremberg, Germany) with the revision and giving useful advice.
The authors declare no conflicts of interest.
EAZ: early activation zone; ECG: electrocardiography; ECGI: non-invasive electrocardiographic imaging; EF: ejection fraction; LV: left ventricle; PVCs: premature ventricular contractions; RBBB: right bundle branch block; cCT: cardiac computer tomography; cMRI: cardiac magnetic resonance.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Figure 1. Case N1. Sinus rhythm, monomorphic premature ventricular contractions with bigeminy pattern.
Figure 2. Schematic representation of the workflow, starting from the electrocardiographic (ECG) registration, proceeding to imaging and 3D segmentation, to invasive mapping, and, finally, to the fusion imaging of non-invasive and invasive data.
Figure 3. Upper row: example of recording computer tomography (CT). (A,B)—CT torso acquisition to capture applied metal 8-electrode strips (‘LungLowDose’ scan without contrast); (C)—contrast CT heart acquisition. Lower row: example of recording magnetic resonance imaging (MRI). (D,E)—torso series (t1_vibe_fs_cor_bh) in coronal plane to capture applied carbon MRI-compatible 8-electrode strips; (F)—MRI contrast heart acquisition with t1_vibe_fs_tra_p2_bh_iso_320 sequence.
Figure 4. Case N1. Sinus rhythm, premature ventricular contraction. Three-dimensional representation of the non-invasive isochronal map on the left, and of the invasive isochronal map on the right. EAZ—early activation zone (red color). Approximately 41 mm distance from EAZ to mitral annulus on non-invasive isochronal map; 36 mm distance from EAZ to mitral annulus on invasive isochronal map.
Figure 5. Case N1. Sinus rhythm, premature ventricular contraction. Three-dimensional representation of the endocardial non-invasive isochronal map on the left, of the invasive isochronal map in the middle, and the fusion of non-invasive and invasive maps on the right. EAZ—early activation zone. White marker—the earliest activation site of EAZ. Approximately 4 mm distance between non-invasive and invasive earliest activation site on fusion model.
Figure 6. Case N2. Sinus rhythm, monomorphic premature ventricular contractions with bigeminy pattern and right bundle branch morphology.
Figure 7. Case N2. Sinus rhythm, premature ventricular contraction. Three-dimensional representation of the endocardial non-invasive isochronal map on the left, of the invasive isochronal map in the middle, and the fusion of non-invasive and invasive maps on the right. EAZ—early activation zone. White marker—the earliest activation site of EAZ. Approximately 7 mm distance between non-invasive and invasive earliest activation site on fusion model.
Figure 9. Case N3. Sinus rhythm, premature ventricular contraction. Three-dimensional representation of the endocardial non-invasive isochronal map on the left, of the invasive isochronal map in the middle, and the fusion of non-invasive and invasive maps on the right. EAZ—early activation zone; LV—left ventricle; RV—right ventricle; RVOT—right ventricular outflow tract. White marker—the earliest activation site of EAZ. Approximately 4 mm distance between non-invasive and invasive earliest activation site on fusion model.
Arrhythmias’ data.
Case 1 | Case 2 | Case 3 | |
---|---|---|---|
Cardiac CT/MRI | cCT | cMRI | cCT |
Structural cardiomyopathy | Ischaemic (previous inferior wall infarction) | None (aortic valve insufficiency) | None |
EF LV (%) | 29 | 48 | 64 |
PVCs burden % on a Holter monitors | 20–50 | 30 | 5 |
PVCs morphology | Monomorphic | Monomorphic | Monomorphic |
12 lead ECG | Superior axis; | Superior axis; | Discordance in QRS complex (positive in II, negative in III); |
Antiarrhythmic | Beta-blockers | Beta-blockers, Flecainid, Propafenone | Beta-blockers, |
Number and material of ECG strips used for each case.
Number of | Number of Unipolar Electrodes | Electrode Material | |
---|---|---|---|
Case 1 | 26 | 208 | Metal |
Case 2 | 28 | 224 | Carbon |
Case 3 | 21 | 168 | Metal |
Results of invasive and non-invasive mapping.
Case 1 | Case 2 | Case 3 | |
---|---|---|---|
Position of EAZ | |||
Invasive | inferior wall LV | inferoseptal apical LV | inferoseptal basal RV |
Non-invasive | inferior wall LV | inferoseptal apical LV | inferoseptal basal RV |
Area of EAZ, cm2 | |||
Invasive | 4.3 | 7.1 | 0.4 |
Non-invasive | 4.5 | 7 | 0.6 |
Distance from EAZ to annulus, mm | |||
Invasive | 36 | 73 | 9 |
Non-invasive | 41 | 75 | 12 |
Distance between the earliest activation site on invasive and non-invasive map, mm | 4 | 7 | 4 |
References
1. Tanner, H.; Hindricks, G.; Schirdewahn, P.; Kobza, R.; Dorszewski, A.; Piorkowski, C.; Gerds-Li, J.-H.; Kottkamp, H. Outflow tract tachycardia with R/S transition in lead V3: Six different anatomic approaches for successful ablation. J. Am. Coll. Cardiol.; 2005; 45, pp. 418-423. [DOI: https://dx.doi.org/10.1016/j.jacc.2004.10.037]
2. Chen, J.; Hoff, P.I.; Rossvoll, O.; De Bortoli, A.; Solheim, E.; Sun, L.; Schuster, P.; Larsen, T.; Ohm, O.-J. Ventricular arrhythmias originating from the aortomitral continuity: An uncommon variant of left ventricular outflow tract tachycardia. Europace; 2011; 14, pp. 388-395. [DOI: https://dx.doi.org/10.1093/europace/eur318] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21979993]
3. Zhou, X.; Fang, L.; Wang, Z.; Liu, H.; Mao, W. Comparative analysis of electrocardiographic imaging and ECG in predicting the origin of outflow tract ventricular arrhythmias. J. Int. Med. Res.; 2020; 48, 300060520913132. [DOI: https://dx.doi.org/10.1177/0300060520913132] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32228331]
4. Ramanathan, C.; Ghanem, R.N.; Jia, P.; Ryu, K.; Rudy, Y. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat. Med.; 2004; 10, pp. 422-428. [DOI: https://dx.doi.org/10.1038/nm1011]
5. Intini, A.; Goldstein, R.N.; Jia, P.; Ramanathan, C.; Ryu, K.; Giannattasio, B.; Gilkeson, R.; Stambler, B.S.; Brugada, P.; Stevenson, W.G. et al. Electrocardiographic imaging (ECGI), a novel diagnostic modality used for mapping of focal left ventricular tachycardia in a young athlete. Heart Rhythm; 2005; 2, pp. 1250-1252. [DOI: https://dx.doi.org/10.1016/j.hrthm.2005.08.019]
6. Berger, T.; Pfeifer, B.; Hanser, F.F.; Hintringer, F.; Fischer, G.; Netzer, M.; Trieb, T.; Stuehlinger, M.; Dichtl, W.; Baumgartner, C. et al. Single-Beat Noninvasive Imaging of Ventricular Endocardial and Epicardial Activation in Patients Undergoing CRT. PLoS ONE; 2011; 6, e16255. [DOI: https://dx.doi.org/10.1371/journal.pone.0016255] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21298045]
7. Revishvili, A.S.; Wissner, E.; Lebedev, D.S.; Lemes, C.; Deiss, S.; Metzner, A.; Kalinin, V.V.; Sopov, O.V.; Labartkava, E.Z.; Kalinin, A.V. et al. Validation of the mapping accuracy of a novel non-invasive epicardial and endocardial electrophysiology system. Europace; 2015; 17, pp. 1282-1288. [DOI: https://dx.doi.org/10.1093/europace/euu339] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25643987]
8. Yu, L.; Jin, Q.; Zhou, Z.; Wu, L.; He, B. Three-Dimensional Noninvasive Imaging of Ventricular Arrhythmias in Patients with Premature Ventricular Contractions. IEEE Trans. Biomed. Eng.; 2017; 65, pp. 1495-1503. [DOI: https://dx.doi.org/10.1109/TBME.2017.2758369]
9. Misra, S.; van Dam, P.; Chrispin, J.; Assis, F.; Keramati, A.; Kolandaivelu, A.; Berger, R.; Tandri, H. Initial validation of a novel ECGI system for localization of premature ventricular contractions and ventricular tachycardia in structurally normal and abnormal hearts. J. Electrocardiol.; 2018; 51, pp. 801-808. [DOI: https://dx.doi.org/10.1016/j.jelectrocard.2018.05.018]
10. Krummen, D.E.; Villongco, C.T.; Ho, G.; Schricker, A.A.; Field, M.E.; Sung, K.; Kacena, K.A.; Martinson, M.S.; Hoffmayer, K.S.; Hsu, J.C. et al. Forward-Solution Noninvasive Computational Arrhythmia Mapping: The VMAP Study. Circ. Arrhythmia Electrophysiol.; 2022; 15, pp. 595-608. [DOI: https://dx.doi.org/10.1161/CIRCEP.122.010857]
11. Webber, M.; Joy, G.; Bennett, J.; Chan, F.; Falconer, D.; Shiwani, H.; Davies, R.H.; Krausz, G.; Tanackovic, S.; Guger, C. et al. Technical development and feasibility of a reusable vest to integrate cardiovascular magnetic resonance with electrocardiographic imaging. J. Cardiovasc. Magn. Reson.; 2023; 25, 73. [DOI: https://dx.doi.org/10.1186/s12968-023-00980-7]
12. Potyagaylo, D.; Chmelevsky, M.; Budanova, M.; Zubarev, S.; Treshkur, T.; Lebedev, D. Combination of lead-field theory with cardiac vector direction: ECG imaging of septal ventricular activation. J. Electrocardiol.; 2019; 57, pp. S40-S44. [DOI: https://dx.doi.org/10.1016/j.jelectrocard.2019.08.003]
13. Potyagaylo, D.; Chmelevsky, M.; van Dam, P.; Budanova, M.; Zubarev, S.; Treshkur, T.; Lebedev, D. ECG Adapted Fastest Route Algorithm to Localize the Ectopic Excitation Origin in CRT Patients. Front. Physiol.; 2019; 10, 183. [DOI: https://dx.doi.org/10.3389/fphys.2019.00183]
14. Wissner, E.; Saguner, A.M.; Metzner, A.; Chmelesky, M.; Tsyganov, A.; Deiss, S.; Maurer, T.; Kuck, K.-H. Radiofrequency ablation of premature ventricular contractions originating from the aortomitral continuity localized by use of a novel noninvasive epicardial and endocardial electrophysiology system. Heart Case Rep.; 2016; 2, pp. 255-257. [DOI: https://dx.doi.org/10.1016/j.hrcr.2016.02.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28491682]
15. Namdar, M.; Chmelevsky, M.; Hachulla, A.-L.; Shah, D.C. Precise Noninvasive ECG Mapping Derived Localization of the Origin of an Epicardial Ventricular Tachycardia. Circ. Arrhythmia Electrophysiol.; 2016; 9, e003949. [DOI: https://dx.doi.org/10.1161/CIRCEP.116.003949] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27956434]
16. Wissner, E.; Revishvili, A.; Metzner, A.; Tsyganov, A.; Kalinin, V.; Lemes, C.; Saguner, A.M.; Maurer, T.; Deiss, S.; Sopov, O. et al. Noninvasive epicardial and endocardial mapping of premature ventricular contractions. Europace; 2016; 19, pp. 843-849. [DOI: https://dx.doi.org/10.1093/europace/euw103] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27207812]
17. Parreira, L.; Carmo, P.; Adragão, P.; Marinheiro, R.; Budanova, M.; Cardim, N.; Gonçalves, P. Successful ablation of premature ventricular contractions exclusively guided by epicardial and endocardial non-invasive mapping (ECGI) and confirmed by substrate mapping. J. Electrocardiol.; 2020; 62, pp. 103-106. [DOI: https://dx.doi.org/10.1016/j.jelectrocard.2020.07.003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32841865]
18. Parreira, L.; Carmo, P.; Nunes, S.; Marinheiro, R.; Mesquita, D.; Zubarev, S.; Chmelevsky, M.; Hitchen, R.; Ferreira, A.; Pinho, J. et al. Electrocardiographic imaging to guide ablation of ventricular arrhythmias and agreement between two different systems. J. Electrocardiol.; 2023; 80, pp. 143-150. [DOI: https://dx.doi.org/10.1016/j.jelectrocard.2023.06.003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37390586]
19. Zubarev, S.; Chmelevsky, M.; Potyagaylo, D.; Budanova, M.; Rud, S.; Ryzhkov, A.; Lebedev, D. Comparison of Left Ventricular Late Activation Zones Determined Using Noninvasive Electrocardiographic Imaging with Sequential Computed and Magnetic Resonance Tomography. Proceedings of the 2018 Computing in Cardiology Conference (CinC); Maastricht, The Netherlands, 23–26 September 2018; pp. 1-4. [DOI: https://dx.doi.org/10.22489/CinC.2018.347]
20. Jamil-Copley, S.; Bokan, R.; Kojodjojo, P.; Qureshi, N.; Koa-Wing, M.; Hayat, S.; Kyriacou, A.; Sandler, B.; Sohaib, A.; Wright, I. et al. Noninvasive electrocardiographic mapping to guide ablation of outflow tract ventricular arrhythmias. Heart Rhythm; 2014; 11, pp. 587-594. [DOI: https://dx.doi.org/10.1016/j.hrthm.2014.01.013]
21. Erkapic, D.; Greiss, H.; Pajitnev, D.; Zaltsberg, S.; Deubner, N.; Berkowitsch, A.; Möllman, S.; Sperzel, J.; Rolf, A.; Schmitt, J. et al. Clinical impact of a novel three-dimensional electrocardiographic imaging for non-invasive mapping of ventricular arrhythmias--a prospective randomized trial. Europace; 2014; 17, pp. 591-597. [DOI: https://dx.doi.org/10.1093/europace/euu282]
22. Hocini, M.; Shah, A.J.; Neumann, T.; Kuniss, M.; Erkapic, D.; Chaumeil, A.; Copley, S.-J.; Lim, P.B.; Kanagaratnam, P.; Denis, A. et al. Focal Arrhythmia Ablation Determined by High-Resolution Noninvasive Maps: Multicenter Feasibility Study. J. Cardiovasc. Electrophysiol.; 2015; 26, pp. 754-760. [DOI: https://dx.doi.org/10.1111/jce.12700]
23. van Dam, P.M.; Boyle, N.G.; Laks, M.M.; Tung, R. Localization of premature ventricular contractions from the papillary muscles using the standard 12-lead electrocardiogram: A feasibility study using a novel cardiac isochrone positioning system. Europace; 2016; 18, pp. S16-S22. [DOI: https://dx.doi.org/10.1093/europace/euw347]
24. Cuculich, P.S.; Schill, M.R.; Kashani, R.; Mutic, S.; Lang, A.; Cooper, D.; Faddis, M.; Gleva, M.; Noheria, A.; Smith, T.W. et al. Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. N. Engl. J. Med.; 2017; 377, pp. 2325-2336. [DOI: https://dx.doi.org/10.1056/NEJMoa1613773]
25. Tsyganov, A.; Wissner, E.; Metzner, A.; Mironovich, S.; Chaykovskaya, M.; Kalinin, V.; Chmelevsky, M.; Lemes, C.; Kuck, K.-H. Mapping of ventricular arrhythmias using a novel noninvasive epicardial and endocardial electrophysiology system. J. Electrocardiol.; 2018; 51, pp. 92-98. [DOI: https://dx.doi.org/10.1016/j.jelectrocard.2017.07.018] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28912073]
26. Haïssaguerre, M.; Hocini, M.; Cheniti, G.; Duchateau, J.; Sacher, F.; Puyo, S.; Cochet, H.; Takigawa, M.; Denis, A.; Martin, R. et al. Localized Structural Alterations Underlying a Subset of Unexplained Sudden Cardiac Death. Circ. Arrhythmia Electrophysiol.; 2018; 11, e006120. [DOI: https://dx.doi.org/10.1161/CIRCEP.117.006120]
27. Duchateau, J.; Sacher, F.; Pambrun, T.; Derval, N.; Chamorro-Servent, J.; Denis, A.; Ploux, S.; Hocini, M.; Jaïs, P.; Bernus, O. et al. Performance and limitations of noninvasive cardiac activation mapping. Heart Rhythm; 2018; 16, pp. 435-442. [DOI: https://dx.doi.org/10.1016/j.hrthm.2018.10.010] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30385382]
28. Parreira, L.; Carmo, P.; Marinheiro, R.; Mesquita, D.; Chmelevsky, M.; Ferreira, A.; Marques, L.; Pinho, J.; Chambel, D.; Nunes, S. et al. Assessment of wave front activation duration and speed across the right ventricular outflow tract using electrocardiographic imaging as predictors of the origin of the premature ventricular contractions: A validation study. J. Electrocardiol.; 2022; 73, pp. 68-75. [DOI: https://dx.doi.org/10.1016/j.jelectrocard.2022.05.005]
29. Graham, A.J.; Orini, M.; Zacur, E.; Dhillon, G.; Daw, H.; Srinivasan, N.T.; Martin, C.; Lane, J.; Mansell, J.S.; Cambridge, A. et al. Evaluation of ECG Imaging to Map Hemodynamically Stable and Unstable Ventricular Arrhythmias. Circ. Arrhythmia Electrophysiol.; 2020; 13, e007377. [DOI: https://dx.doi.org/10.1161/CIRCEP.119.007377]
30. Graham, A.J.; Orini, M.; Zacur, E.; Dhillon, G.; Daw, H.; Srinivasan, N.T.; Lane, J.D.; Cambridge, A.; Garcia, J.; O’reilly, N.J. et al. Simultaneous Comparison of Electrocardiographic Imaging and Epicardial Contact Mapping in Structural Heart Disease. Circ. Arrhythmia Electrophysiol.; 2019; 12, e007120. [DOI: https://dx.doi.org/10.1161/CIRCEP.118.007120]
31. Nguyen, D.; Jeudy, J.; Restrepo, A.J.; Dickfeld, T.-M. A Novel Use of Noninvasive Registered Electrocardiographic Imaging Map for Localization of VT and PVC. JACC Case Rep.; 2021; 3, pp. 591-593. [DOI: https://dx.doi.org/10.1016/j.jaccas.2021.01.031]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
In patients with premature ventricular contractions (PVCs), non-invasive mapping could locate the PVCs’ origin on a personalized 3-dimensional (3D) heart model and, thus, facilitate catheter ablation therapy planning. The aim of our report is to evaluate its accuracy compared to invasive mapping in terms of assessing the PVCs’ early activation zone (EAZ). For this purpose, non-invasive electrocardiographic imaging (ECGI) was performed using the Amycard 01C system (EP Solutions SA, Switzerland) in three cases. In the first step, a multichannel ECG (up to 224 electrodes) was recorded, and the dominant PVCs were registered. Afterward, a cardiac computed tomography (in two cases) or magnetic resonance imaging (in one case) investigation was carried out acquiring non-contrast torso scans for 8-electrode strip visualization and contrast heart acquisition. For the reconstructed epi/endocardial meshes of the heart, non-invasive isochronal maps were generated for the selected multichannel ECG fragments. Then, the patients underwent an invasive electrophysiological study, and the PVCs’ activation was evaluated by a 3D mapping system (EnSite NavX Precision, Abbott). Finally, using custom-written software, we performed 3D fusion of the non-invasive and invasive models and compared the resulting isochronal maps. A qualitative analysis in each case showed the same early localization of the dominant PVC on the endocardial surface when comparing the non-invasive and invasive isochronal maps. The distance from the EAZ to the mitral or tricuspid annulus was comparable in the invasive/non-invasive data (36/41 mm in case N1, 73/75 mm in case N2, 9/12 mm in case N3). The area of EAZ was also similar between the invasive/non-invasive maps (4.3/4.5 cm2 in case N1, 7.1/7.0 cm2 in case N2, 0.4/0.6 cm2 in case N3). The distances from the non-invasive to invasive earliest activation site were 4 mm in case N1, 7 mm in case N2, and 4 mm in case N3. Such results were appropriate to trust the clinical value of the preoperative data in these cases. In conclusion, the non-invasive identification of PVCs before an invasive electrophysiological study can guide clinical and interventional decisions, demonstrating appropriate accuracy in the estimation of focus origin.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Division of Cardiac Electrophysiology, Department for Cardiology, Klinikum Fuerth, 90766 Fuerth, Germany;
2 Division of Cardiac Electrophysiology, Department for Cardiology, Klinikum Fuerth, 90766 Fuerth, Germany;
3 Radiology Department, Klinikum Fuerth, 90766 Fuerth, Germany;